Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

346
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
346
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

184
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
184
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

347
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
347
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

290
Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
290
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

301
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
301
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

348
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
348

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seeing the Unseen: Deep Learning and the Pre-Therapy Cardiac Phenotype in Cardiotoxicity.

JACC. Cardiovascular imaging·2026
Same author

Association Between Regional Cardiac Radiation Dose and Magnetic Resonance Imaging Myocardial Contractility Parameters: A Prospective Pilot Study.

Tomography (Ann Arbor, Mich.)·2026
Same author

Cardiac Magnetic Resonance Scan Efficiency.

Magnetic resonance imaging clinics of North America·2026
Same author

Bridging the Gap: Cardiac Magnetic Resonance Guidelines to Clinical Practice in Sport Cardiology.

Magnetic resonance imaging clinics of North America·2026
Same author

Strain Imaging in Heart Failure.

Magnetic resonance imaging clinics of North America·2026
Same author

Cardiovascular Magnetic Resonance: Innovation, Integration, and Clinical Impact.

Magnetic resonance imaging clinics of North America·2026

Related Experiment Video

Updated: Jan 5, 2026

Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
11:13

Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging

Published on: May 24, 2021

7.0K

Left Ventricular Hypertrophy: Evaluation With Cardiac MRI.

Karen G Grajewski1, Jadranka Stojanovska1, El-Sayed H Ibrahim2

  • 1University of Michigan Hospital and Health Systems, Department of Radiology, Division of Cardiothoracic Imaging, Ann Arbor, MI.

Current Problems in Diagnostic Radiology
|October 22, 2019
PubMed
Summary
This summary is machine-generated.

Cardiac MRI (CMR) aids in diagnosing the causes of left ventricular hypertrophy (LVH). CMR provides detailed analysis of hypertrophy, function, and tissue characteristics to guide prognosis and treatment.

More Related Videos

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
06:34

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography

Published on: October 28, 2020

4.5K
Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

3.3K

Related Experiment Videos

Last Updated: Jan 5, 2026

Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
11:13

Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging

Published on: May 24, 2021

7.0K
Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
06:34

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography

Published on: October 28, 2020

4.5K
Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

3.3K

Area of Science:

  • Cardiology
  • Radiology
  • Medical Imaging

Background:

  • Left ventricular hypertrophy (LVH) presents diverse etiologies, often challenging clinical diagnosis.
  • Cardiac Magnetic Resonance (CMR) is increasingly utilized for evaluating LVH.
  • Accurate etiological diagnosis is crucial for effective patient management.

Purpose of the Study:

  • To review CMR findings across various causes of LVH.
  • To emphasize CMR's role in etiological determination.
  • To highlight CMR's emerging utility in risk stratification for LVH patients.

Main Methods:

  • Review of CMR imaging findings in different LVH etiologies.
  • Emphasis on diagnostic patterns and tissue characterization techniques.
  • Discussion of CMR's contribution to risk assessment.

Main Results:

  • CMR precisely quantifies hypertrophy severity and distribution.
  • CMR effectively evaluates ventricular function and provides tissue characterization.
  • CMR findings aid in differentiating various causes of LVH.

Conclusions:

  • CMR is invaluable for assessing LVH, determining its cause, and guiding therapy.
  • CMR enhances understanding of LVH pathophysiology and prognosis.
  • Advanced CMR techniques improve diagnostic accuracy and risk stratification.